Aimmune Therapeutics, Inc.

Aimmune Therapeutics, Inc. (AIMT) shares gained 6.31% today (2020-02-03). Is it the right time to buy?

On: February 4

What’s happening at Aimmune Therapeutics, Inc. (NasdaqGS:AIMT)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 6.31% (or 1.96 points) to $33.01 from its previous close of $31.05. So is it the right moment toRead More →

Real Estate

How to buy a property without a budget, or with a small one, in the UK?

Buying a property without a traditional budget in the UK is challenging but not impossible.

Business

Due Diligence: What is it and how to do it?

A business that seeks investments or wants to sell its activities must certainly produce a

Finance and Investments

Apple has increased its venture capital commitment for minority-owned enterprises to $50 million

Apple recently announced an additional $25 million investment in three funds that work with minority-owned

Business

The Beauty of Accounting Equations

A company’s financial situation reflects the amount of resources it has as well as the

Finance and Investments

Option Directional Trade Management

When used to trade the market directionally, options offer excellent position management and risk control